Commentary
Article
From newsworthy moments to groundbreaking research, these were the most-read community pharmacy-related articles from Pharmacy Times in 2023.
1. Significant Association Found Between Vitamin D, Improved Insulin Resistance
Researchers say vitamin D supplementation could be a low-cost and effective avenue for the reduction of insulin resistance and better outcomes in preventing and treating diabetes. Read More Here.
2. FDA Issues Fast Track Designation to ADP101 for Mono-, Multi-Food Allergies
The designation allows expedited development of ADP101 as a treatment for food allergy in children ages 4 to 17 with confirmed allergy to 1 or more of the 15 foods in the drug product. Read More Here.
3. Study Finds Comorbidities, Pre-Existing Disease Have Significant Impact On COVID-19 Outcomes
The study also found significant evidence of outcomes disparities between minority populations and White populations. Read More Here.
4. Patient-Reported Questionnaire Could Aid the Evaluation of Respiratory Syncytial Virus Symptoms
Findings suggest that psychometric tests used for the Respiratory Infection Intensity and Impact Questionnaire provide reliable, constructive validity, and responsive evidence to detect onset symptoms of RSV. Read More Here.
5. Immunoprophylaxis Guidance for RSV Not Aligned With Current Hospitalization Patterns, Study Finds
Investigators urge policymakers to establish flexible models that maximize coverage when respiratory syncytial virus activity is high and minimize unnecessary doses when viral activity is low. Read More Here.
FDA Accepts NDA for Paltusotine to Treat Adult Patients With Acromegaly